Olivier Nataf
Regional Commercial Lead, US/Canada, AstraZeneca Americas
11 years with AstraZeneca in France, US, Global and Americas (US, Canada, Mexico and South America) across the product life-cycle (new products, pre-launch, launch and mature) and disease areas (Urology, Oncology, Diabetes, Neuroscience, Infection) in Brand Marketing, Strategic Marketing, Commercial Operations and Sales roles with Alliance and Team Leadership experience.
40 contactsBrand Director, US/Global Marketing - New Products, AstraZeneca Global Marketing & Sales Organisation
2011 - 2012Within the Global Marketing and Sales Organization, responsible for the US strategy and business case developement for investment decisions (internal and external) in Neuroscience
2009 - 2011Led the Health Care Professionals Launch execution for Onglyza, then go-to-market strategy and launch readiness for Kombiglyze XR in the US.
2007 - 2009Responsible for selling a portfolio of Breast Cancer drugs in the West Chicago area: Abraxane (infusion chemotherapy), Faslodex (injectable hormonotherapy) and Arimidex (oral hormonotherapy)
2005 - 2006Leader of the Prostate Cancer Marketing team.
2001 - 2005Progressive core Marketing experience, including the Launch of Casodex150mg in France.